Adverse Effects of Antimalarials: An Update

Drug Safety

Volumn 8, Issue 4, 1993, Pages 295-311

  Luzzi, Graz A ^a   Peto, Tim E A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISIN DERIVATIVE; ARTEMISININ; CHLOROQUINE; CIMETIDINE; DAPSONE; DIGOXIN; FANSIDAR; FOLIC ACID ANTAGONIST; HALOFANTRINE; HYDROXYCHLOROQUINE; MALOPRIM; MEFLOQUINE; MELANIN; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; RIFAMPICIN; SULFADOXINE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ADULT; ADVERSE DRUG REACTION; AGRANULOCYTOSIS; BLOOD DYSCRASIA; CARDIOTOXICITY; CHILD; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SAFETY; FEMALE; HEMOLYTIC ANEMIA; HUMAN; KIDNEY FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; NEUROTOXICITY; NEUTROPENIA; NEWBORN; ORGANIC BRAIN SYNDROME; PREGNANCY; PREGNANCY COMPLICATION; PSORIASIS; RETINOPATHY; REVIEW; SHOCK; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TERATOGENICITY; TOXIC EPIDERMAL NECROLYSIS; VERTIGO; VISUAL IMPAIRMENT;

ANIMAL; ANTIMALARIALS; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; INFANT, NEWBORN; PREGNANCY;

EID: 0027538367     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/00002018-199308040-00004     Document Type: Review

References (107)

1. Fansidar® data sheet
2. Lariam® data sheet
3. Pyrimethamine poisoning
4. The influence of chloroquine and related drugs on psoriasis and keratoderma blenorrhagica
5. Fatal dapsone agranulocytosis in a Melanesian
6. Quinine toxicity
7. Malaria chemoprophylaxis with mefloquine
8. Complications of quinine poisoning
9. Megaloblastic anaemia and pancytopenia due to proguanil in patients with, chronic renal failure
10. Three hundred years of the Peruvian fever bark
11. Agranulocytosis associated with Maloprim
12. Halofantrine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic potential
13. Fatal acute chloroquine poisoning in children
14. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man
15. Centers for Disease Control: revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant P. falciparum
16. Recommendations for the prevention of malaria among travelers (leads from the Morbidity and Mortality Weekly Report)
17. Drug-induced haemolysis in glucose6-phosphate dehydrogenase deficiency
18. Malaria in paediatric practice
19. Clinical problems associated with the use of primaquine as a tissue schizonticidal and gametocytocidal drug
20. Successful treatment of falciparum malaria in pregnancy with mefloquine
21. Effect of chloroquine chemoprophylaxis during pregnancy on birth-weight: results of a randomized trial
22. Photosensitivity to pyrimethamine?
23. Mouth ulceration associated with proguanil
24. A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria
25. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency
26. Ocular effects and safety of antimalarials
27. Editorial. Pyrimethamine combinations in pregnancy. Lancet 2: 1005–1007, 1983
28. Editorial. Halofantrine in the treatment of malaria. Lancet 2: 537–538, 1989
29. Editorial. Rediscovering wormwood — qinghaosu for malaria. Lancet 339: 649–651, 1992
30. Excretion of mefloquine in human breast milk
31. Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon
32. Dihydrofolate reductase inhibitors
33. Antimalarial prophylaxis in pregnant Nigerian women
34. Agranulocytosis associated with malaria prophylaxis and Maloprim
35. Doxyxycline prophylaxis in malaria
36. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria
37. Hairloss and scaling with proguanil
38. Teratogenicity of pyrimethamine
39. Malaria prophylaxis among British residents of Lilongwe and Kasungu districts, Malawi
40. The ototoxicity of chloroquine phosphate
41. Frequency of neutropenia associated with amodiaquine prophylaxis
42. Adverse reactions to sulfadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis
43. Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique
44. Clinical experience with halofantrine in the treatment of malaria
45. Use of mefloquine in epileptic patients
46. Quinidine-induced hypoprothrombinaemic haemorrhage in patients on chronic warfarin therapy
47. Quinine and severe falciparum malaria in late pregnancy
48. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria
49. Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand
50. Mefloquine for multidrug-resistant malaria
51. Treatment of primaquine-resistant Plasmodium vivax malaria
52. Fatal chloroquine poisoning in a child: experience with peritoneal dialysis
53. Fansidar hypersensitivity pneumonitis
54. Ocular safety of huge cumulative antimalarial dosage
55. Antimalarial drugs for rheumatoid arthritis
56. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis
57. Induction of labor and abortion with quinine infusion
58. Proguanil and mouth ulcers
59. Plasmodium falciparum malaria in pregnancy: a review
60. Agranulocytosis due to dapsone
61. Chloroquine and psoriasis
62. Doxycyc-line prophylaxis for falciparum malaria
63. Antimalarial drugs and pregnancy
64. Quinine treatment of severe falciparum malaria in African children: randomized comparison of three regimens
65. Effect of quinine on plasma concentration and renal digoxin clearance
66. Chloroquine: ophthalmological safety and clinical assessment in rheumatoid arthritis
67. Drug resistance in malaria — a perspective
68. Primaquine and other 8-aminoquinolines
69. Toxicity of antimalarial drugs
70. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis
71. Intravenous quinidine for the treatment of severe falciparum malaria: clinical and pharmacokinetic studies
72. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria
73. Serious adverse reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain
74. Tetracycline prophylaxis in malaria
75. Treatment of severe chloroquine poisoning
76. Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria
77. Haemolytic anaemia induced by dapsone through breast milk
78. Single dose kinetics of mefloquine in man
79. Binding of quinine to plasma proteins in falciparum malaria
80. Dapsone neuropathy — report of three cases and pathologic features of a motor nerve
81. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome
82. Chloroquine-as-sociated pruritus in a European
83. Severe cutaneous reactions to sulfadoxine/pyrimethamine in Switzerland
84. Neuropsychiatric side-effects of mefloquine
85. Pruritus and antimalarial drugs in Africans
86. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar)
87. Drugs with quinine-like action
88. Antimalarial agents: chloroquine, hydroxychloroquine and quinacrine
89. Accumulation of chorioretinotoxic drugs in the foetal eye
90. A case of pyrimethamine intoxication in a Papuan child
91. Dapsone-induced peripheral neuropathy: case report and review
92. Effects of cimetidine and ranitidine on the pharmacokinetics of quinine
93. Pyrimethamine/sulfadoxine for falciparum malaria
94. Drugs used in the chemotherapy of protozoal infections: malaria
95. Neuropsychiatric side effects after the use of mefloquine
96. Treatment and prophylaxis of falciparum malaria
97. Chloroquine treatment of severe malaria in children: pharmacokinetics, toxicity and new dosage recommendations
98. Comparison of artemether and chloroquine for severe malaria in Gambian children
99. The management of severe malaria
100. Severe hypoglycemia and hyperinsulinemia in falciparum malaria
101. Parenteral chloroquine for treating falciparum malaria
102. Safety of chloroquine in chemosuppression of malaria during pregnancy
103. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar)